PUMA® - PUMA releases preliminary results for the fourth quarter and financial year 2021
PUMA® - Contact
PUMA® - Annual General Meeting
Le azioni Puma torneranno a ruggire? - Word2Invest
PUMA® - PUMA Investor Relations
PUMA® - Annual General Meeting
PUMA Announces Exclusive Formula 1 Partnership | Hypebeast
PUMA® - Financial Calendar
Puma Energy Zambia Plc (PUMA.zm)
PUMA® - Corporate Governance
PUMA® - Annual General Meeting
Le azioni Puma torneranno a ruggire? - Word2Invest
PUMA® - Share
PUMA® - PUMA achieves another record Quarter in Sales and EBIT despite Geopolitical Tensions and Lockdown Measures
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire